Suppr超能文献

桡动脉移植物可改善冠状动脉旁路移植术后的长期生存率。

Radial artery conduits improve long-term survival after coronary artery bypass grafting.

机构信息

Division of Cardiac Surgery and Office of Grants and Research Administration, Beth Israel Medical Center, New York, New York 10003, USA.

出版信息

Ann Thorac Surg. 2010 Oct;90(4):1165-72. doi: 10.1016/j.athoracsur.2010.05.038.

Abstract

BACKGROUND

The second best conduit for coronary artery bypass graft surgery (CABG) is unclear. We sought to determine if the use of a second arterial conduit, the radial artery (RA), would improve long-term survival after CABG using the left internal thoracic artery (LITA) and saphenous vein (SV).

METHODS

We compared the 14-year outcomes in propensity-matched patients undergoing isolated, primary CABG using the LITA, RA, and SV versus CABG using the LITA and only SV. In all, 826 patients from each group had similar propensity-matched demographics and multiple variables. The primary endpoint was all-cause mortality obtained using the Social Security Death Index.

RESULTS

Perioperative outcomes including in hospital mortality (0.1% for the RA patients and 0.2% for the SV patients) were similar. Kaplan-Meier survival at 1, 5, and 10 years was 98.3%, 93.9%, and 83.1% for the RA group versus 97.2%, 88.7%, and 74.3% for the SV group (log rank, p = 0.0011). Cox proportional hazards models showed a lower all-cause mortality in the RA group (hazard ratio 0.72, confidence interval: 0.56 to 0.92, p = 0.0084). Ten-year survivals showed a 52% increased mortality for the SV patients (25.7%) versus the RA patients (16.9%; p = 0.0011). For symptomatic patients, RA patency was 80.7%, which was not different than the LITA patency rate of 86.4% but was superior to the SV patency rate of 46.7% (p < 0.001).

CONCLUSIONS

Using the LITA, SV, and a RA conduit for CABG results in significantly improved long-term survival compared with using the LITA and SV. The use of two arterial conduits offers a clear and lasting survival advantage, likely due to the improved patency of RA grafts. We conclude that RA conduits should be more widely utilized during CABG.

摘要

背景

冠状动脉旁路移植术(CABG)的第二佳移植物尚不清楚。我们旨在确定使用第二条动脉移植物,桡动脉(RA),是否会在使用左内乳动脉(LITA)和大隐静脉(SV)进行 CABG 后改善长期生存。

方法

我们比较了使用 LITA、RA 和 SV 进行的孤立、原发性 CABG 与仅使用 LITA 和 SV 进行的 CABG 的患者在倾向性匹配后 14 年的结果。每组各有 826 名患者,其倾向性匹配的人口统计学和多个变量相似。主要终点是使用社会安全死亡索引获得的全因死亡率。

结果

包括住院死亡率(RA 患者为 0.1%,SV 患者为 0.2%)在内的围手术期结果相似。RA 组的 1、5 和 10 年 Kaplan-Meier 生存率分别为 98.3%、93.9%和 83.1%,SV 组分别为 97.2%、88.7%和 74.3%(对数秩检验,p=0.0011)。Cox 比例风险模型显示 RA 组的全因死亡率较低(风险比 0.72,置信区间:0.56 至 0.92,p=0.0084)。10 年生存率显示 SV 患者的死亡率增加了 52%(25.7%),而 RA 患者的死亡率为 16.9%(p=0.0011)。对于有症状的患者,RA 通畅率为 80.7%,与 LITA 通畅率 86.4%没有差异,但优于 SV 通畅率 46.7%(p<0.001)。

结论

与仅使用 LITA 和 SV 相比,使用 LITA、SV 和 RA 移植物进行 CABG 可显著改善长期生存。使用两条动脉移植物可提供明显且持久的生存优势,这可能归因于 RA 移植物的通畅性提高。我们得出结论,RA 移植物在 CABG 中应更广泛地应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验